U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06841224) titled 'The Factors Affecting IPP in Peritoneal Dialysis Patients with Polycystic Kidney Disease' on Feb. 18.
Brief Summary: Background: Polycystic kidney disease (PKD) is the most common hereditary kidney disease. Peritoneal dialysis (PD) in such patients is restricted because the significantly enlarged kidneys and liver may lead to the increase of intraperitoneal pressure (IPP). Increased IPP points to higher risk of abdominal wall complications and limited infusion volume that cause insufficient dialysis adequacy. Therefore, monitoring IPP is especially important in patients with polycystic kidney disease. However, the standard measureme...